No tax




Security policy (edit with Customer reassurance module)


Delivery policy (edit with Customer reassurance module)


Return policy (edit with Customer reassurance module)

Active ingredient and dosage form

Cardura - tablets:

1 tab. contains Doxazosin (in the form of mesylate) 1, 2 and 4 mg, excipients: starch sodium glycolate; MCC; lactose; Magnesium stearate; sodium lauryl sulfate; in packing of 14 and 30 pieces.

Mechanism of action

Cardura has a vasodilating effect. Blocks postsynaptic alpha1-adrenoreceptors of vessels and alpha1-adrenoreceptors (stroma and capsules of the prostate gland, bladder neck).

Indications and usage

Hypertension, urinary tract obstruction and symptoms due to benign prostatic hyperplasia.


Hypersensitivity (including other quinazolines).

Pregnancy and Breastfeeding

Perhaps if the expected effect of therapy outweighs the potential risk to the fetus and newborn.

Adverse reactions

Orthostatic reactions, fainting, dizziness, headache, malaise, weakness, drowsiness, asthenia, nausea, edema, rhinitis, incontinence.

Dosage and administration

Cardura is taken orally (in the morning or in the evening).

Arterial hypertension. The dosage ranges from 1 to 16 mg / day. The initial dose of Cardura is 1 mg once a day for 1 or 2 weeks. Over the next 1 or 2 weeks, it is possible to increase the dose to 2 mg once a day. To achieve the desired reduction in blood pressure, if necessary, the daily dose should be increased gradually, observing uniform intervals up to 4, 8 and 16 mg, depending on the severity of the patient's response. The usual recommended dose is 2-4 mg 1 time per day.

Benign prostatic hyperplasia. The initial dose of Cardura is 1 mg once a day. Depending on the individual characteristics of urodynamics and the presence of symptoms of the disease, the dose can be increased to 2 mg, and then to 4 mg and up to a maximum recommended dose of 8 mg. The recommended interval for increasing the dose is 1-2 weeks. The usual recommended dose is 2-4 mg 1 time per day.

Experience with doxazosin in children is absent.

It should be borne in mind that concentration of attention may be weakened (the ability to drive and mechanisms is impaired).

Storage conditions

In a dry, dark place at a temperature of no higher than 30 ° C.

31 Items